Study may widen patient pool that benefits from EPZ-5676 against acute myeloid leukemia
Tuesday, March 1, 2016 - 11:50
in Health & Medicine
The mechanism that gene MN1 uses to cause an aggressive AML subtype is better understood thanks to new research. Drugs targeting weak link in the chain of causation are in clinical trials for other subtypes.